男友太凶猛1v1高h,大地资源在线资源免费观看 ,人妻少妇精品视频二区,极度sm残忍bdsm变态

Global EditionASIA 中文雙語Fran?ais
World
Home / World / Asia-Pacific

Test kit issue of ICMR can be resolved with good will as priority attached to quality of medical exports

chinadaily.com.cn | Updated: 2020-04-28 13:40
Share
Share - WeChat
The novel coronavirus testing kit produced by Guangzhou Wondfo Biotech Co Ltd, [Photo provided to chinadaily.com.cn]

China not only attaches importance to the quality of medical exports, but also takes concrete actions to sincerely help and support India in the fight against COVID-19, said a spokesperson from the Chinese Embassy in India.

Regarding the announcement of the Indian Council of Medical Research to stop using rapid antibody test kits from two Chinese companies, Counselor Ji Rong said, "We hope the Indian side could respect China's goodwill and sincerity, strengthen communication timely with relevant Chinese companies based on facts, and resolve it reasonably and properly."

Both companies are concerned. In their statement, they said the kits have been exported to and well recognized in many countries in Europe, Asia and Latin America. The same kits have been validated and approved by ICMR through National Institute of Virology (NIV), Pune and considered as satisfactory products, as well meeting the quality standards of China and exported countries.

"We have also learned that there are strict requirements for the storage, transportation and use of COVID-19 antibody rapid test kits," Ji said. "Any operation which is not carried out by professionals in accordance with the product specifications will lead to the testing accuracy variations."

ICMR also made it clear that rapid antibody test kits should only be used for surveillance purposes instead of replacing RT-PCR test to diagnose and confirm the cases, and Indian states are advised to strictly abide by the methods and purpose of the usage according to ICMR's clear instructions.

"It is unfair and irresponsible for certain individuals to label Chinese products as "faulty" and look at issues with pre-emptive prejudice," Ji added.

China and India have maintained close communication and cooperation on epidemic prevention and control. Following India's pandemic situation, China has shared its experiences in prevention, control and treatment, and donated medical materials to India.

"We will continue to support India's efforts in fighting COVID-19, strengthen medical and health cooperation, and jointly work with India to overcome the difficulties at an early date, so as to safeguard the safety and health of our peoples as well as global and regional public health security," Ji said.

Most Viewed in 24 Hours
Top
BACK TO THE TOP
English
Copyright 1995 - . All rights reserved. The content (including but not limited to text, photo, multimedia information, etc) published in this site belongs to China Daily Information Co (CDIC). Without written authorization from CDIC, such content shall not be republished or used in any form. Note: Browsers with 1024*768 or higher resolution are suggested for this site.
License for publishing multimedia online 0108263

Registration Number: 130349
FOLLOW US
主站蜘蛛池模板: 蓬莱市| 读书| 上林县| 浦东新区| 天水市| 苍梧县| 彭泽县| 米易县| 哈巴河县| 泰和县| 罗定市| 称多县| 辉南县| 巴彦县| 靖西县| 西和县| 运城市| 古交市| 嫩江县| 左贡县| 巴青县| 安塞县| 若尔盖县| 南部县| 资兴市| 滕州市| 北安市| 柞水县| 延安市| 弋阳县| 兴化市| 凌源市| 九龙城区| 修文县| 兴城市| 吉木萨尔县| 布尔津县| 腾冲县| 龙海市| 宁城县| 高雄县|